OLMA fund manager activity
Olema Pharmaceuticals, Inc · Nasdaq. Reported by 3 tracked fund managers in their 13F filings, Q4 2025 to Q2 2026.
Q2 2026
| Manager | Activity | Shares | Value | % of portfolio | Filed |
|---|---|---|---|---|---|
| Stanley Druckenmiller - Duquesne Family Office | No change | 986,827 | $12,345,000 | 0.28% | Aug 14, 2026 |
| Ken Fisher - Fisher Asset Management | Trimmed | 296,724 | $3,712,015 | 0.00% | Aug 4, 2026 |
Q1 2026
| Manager | Activity | Shares | Value | % of portfolio | Filed |
|---|---|---|---|---|---|
| Stanley Druckenmiller - Duquesne Family Office | New | 986,827 | $14,714,000 | 0.50% | May 15, 2026 |
| Ken Fisher - Fisher Asset Management | New | 299,756 | $4,469,361 | 0.00% | May 5, 2026 |
| Polen Capital Management | Sold out | — | — | 0.00% | May 14, 2026 |